NGL Fine-Chem Limited (NGLFINE.BO)
INR 2040.15
(2.62%)
INR 2040.15
(2.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 201.89 Million | 352.86 Million | 138.34 Million | 273.54 Million | 204.64 Million | 88.46 Million |
| Net Income | 413.16 Million | 273.62 Million | 665.96 Million | 775.89 Million | 120.72 Million | 275.66 Million |
| Depreciation & Amortization | 116.41 Million | 112.91 Million | 103.69 Million | 83.34 Million | 81.12 Million | 63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -326.15 Million | 32.58 Million | -473.94 Million | -340.91 Million | -332.25 Thousand | -191.47 Million |
| Other non-cash items | 383.87 Million | -66.25 Million | -157.36 Million | -244.78 Million | 3.13 Million | -58.72 Million |
| Investing Cash Flow | -285.05 Million | -270.2 Million | -142.13 Million | -245.68 Million | -195.51 Million | -95.44 Million |
| Investments in PPE | -285.24 Million | -314.06 Million | -563.76 Million | -172.11 Million | -151.41 Million | -144.98 Million |
| Acquisitions | 184 Thousand | 10.95 Million | 272.91 Million | 1.43 Million | - | - |
| Investment purchases | - | - | - | -136 Million | -22.43 Million | - |
| Sales/Maturities of investments | - | - | - | 61 Million | - | 4.95 Million |
| Other Investing Activities | 1000.00 | 32.9 Million | 148.72 Million | -1000.00 | -21.65 Million | 44.58 Million |
| Financing Cash Flow | 8.82 Million | -10.81 Million | -10.81 Million | -10.81 Million | -13.03 Million | -3.08 Million |
| Debt repayment | -19.63 Million | -36.14 Million | -159 Million | -119.62 Million | -3.91 Million | -3.08 Million |
| Dividends payments | -10.81 Million | -10.81 Million | -10.81 Million | -10.81 Million | -13.03 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 36.14 Million | 159 Million | 119.62 Million | 3.91 Million | - |
| Accounts receivables | -237.46 Million | -18.94 Million | -264.19 Million | -113.64 Million | 69.31 Million | -54.56 Million |
| Accounts payables | 248 Million | -125.69 Million | 76.21 Million | 87.03 Million | 47.15 Million | -74.19 Million |
| Inventory | -163.1 Million | 290.14 Million | -181.57 Million | -99.53 Million | -92.86 Million | -17.99 Million |
| Other working capital | -173.59 Million | -112.91 Million | -104.39 Million | -214.76 Million | -23.92 Million | -44.71 Million |
| Cash at beginning of period | 78.28 Million | 6.43 Million | 21.03 Million | 3.98 Million | 7.88 Million | 14.86 Million |
| Cash at end of period | 17.2 Million | 78.28 Million | 6.43 Million | 21.03 Million | 3.98 Million | 7.88 Million |
| Capital Expenditure | -285.24 Million | -314.06 Million | -563.76 Million | -172.11 Million | -151.41 Million | -144.98 Million |
| Effect of forex changes on cash | - | - | - | 1000.00 | 1.00 | 3.08 Million |
| Net cash flow / Change in cash | -61.08 Million | 71.84 Million | -14.59 Million | 17.04 Million | -3.9 Million | -6.97 Million |
| Free Cash Flow | -83.34 Million | 38.79 Million | -425.41 Million | 101.42 Million | 53.22 Million | -56.51 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 413.16 Million | 100.33 Million | 104.78 Million | 85.06 Million | 273.62 Million | 93.24 Million |
| Depreciation & Amortization | 116.41 Million | 29.42 Million | 28.9 Million | 28.58 Million | 112.91 Million | 26.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -326.15 Million | - | - | - | 32.58 Million | - |
| Other non-cash items | 383.87 Million | -70.9 Million | -28.9 Million | -28.58 Million | -66.25 Million | -26.79 Million |
| Investing Cash Flow | -285.05 Million | - | - | - | -270.2 Million | - |
| Investments in PPE | -285.24 Million | - | - | - | -314.06 Million | - |
| Acquisitions | 184 Thousand | - | - | - | 10.95 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1000.00 | - | - | - | 32.9 Million | - |
| Financing Cash Flow | 8.82 Million | - | - | - | -10.81 Million | - |
| Debt repayment | -19.63 Million | - | - | - | -36.14 Million | - |
| Dividends payments | -10.81 Million | - | - | - | -10.81 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 36.14 Million | - |
| Accounts receivables | -237.46 Million | - | - | - | -18.94 Million | - |
| Accounts payables | 248 Million | - | - | - | -125.69 Million | - |
| Inventory | -163.1 Million | - | - | - | 290.14 Million | - |
| Other working capital | -173.59 Million | - | - | - | -112.91 Million | - |
| Cash at beginning of period | 78.28 Million | 7.48 Million | -97.29 Million | 78.28 Million | 6.43 Million | -14.96 Million |
| Cash at end of period | 17.2 Million | 66.34 Million | 7.48 Million | 85.06 Million | 78.28 Million | 78.28 Million |
| Capital Expenditure | -285.24 Million | - | - | - | -314.06 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -61.08 Million | 58.85 Million | 104.78 Million | 6.78 Million | 71.84 Million | 93.24 Million |
| Free Cash Flow | -83.34 Million | 58.85 Million | 104.78 Million | 85.06 Million | 38.79 Million | 93.24 Million |
THEMISMED
8929
GZTGF
MTA
BEML
4015